Telomerase activity and telomere length in different areas of renal cell carcinoma

International Journal of Oncology

Volumn 9, Issue 6, 1996, Pages 1227-1232

  Fiedler, Wolfgang ^a,d   Dahse, Regine ^a   Schlichter, Andreas ^b   Junker, Kerstin ^a   Kosmehl, Hartwig ^c   Ernst, Guenther ^a   Schubert, Joerg ^b   Claussen, Uwe ^a  

^a Institute of Human Genetics and Anthropology   (Germany)

^b Clinic of Urology   (Germany)

^c Institute of Pathology   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

RCC; telomerase activity; telomere length; tumor heterogeneity

Indexed keywords

TELOMERASE; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TELOMERE;

EID: 0029833160     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.6.1227     Document Type: Article

References (35)

1. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529, 1989.
2. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992.
3. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
4. Chadeneau C, Hay K, Hirte HW, Gallinger S and Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55: 2533-2536, 1995.
5. Counter CM, Hirte HW, Bacchetti S and Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900-2904, 1994.
6. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA and Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1: 249-255, 1995.
7. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW and Matsuura Y: Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262, 1995.
8. Hiyama E, Golahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA and Shay JW: Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122, 1996.
9. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW: Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87: 895-902, 1995.
10. Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW and Toyama K: Telomerase reactivation in leukemia cells. Int J Oncol 8: 417-421, 1996.
11. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS and Shay JS: Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56: 218-222, 1996.
12. Stoerkel S and van den Berg E: Morphological classification of renal cancer. World J Urol 13: 153-158, 1995.
13. van denBerg E, van der Hout AH, Oosterhuis J, Störkel S, Dijkuizen T, Dam A and Zweeres HM: Cytogenetic analysis of epithelial renal cell tumors - relationship with a new histopathological classification. Int J Cancer 55: 223-227, 1993.
14. Hughson MD, Johnson LD, Silva FG and Kovacs G: Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study. Modern Pathol 6: 449-456, 1993.
15. Golimbu M, Joshi P, Sperber A, Tessler A, Al-Askari S and Morales P: Renal cell carcinoma: survival and prognostic factors Urology 27: 291-301, 1986.
16. Provet J, Tessler A, Brown J, Golimbu M, Bosniak M and Morales P: Partial nephrectomy for renal cell carcinoma: indications, results and implications. J Urol 145: 472-476, 1991.
17. Golimbu M, Al-Askari S, Tessler S and Morales P: Aggressive treatment of metastatic renal cancer. J Urol 136: 805-807, 1986.
18. Sene AP, Hunt L, McMahon, RF and Carroll RN: Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br J Urol 70: 125-134, 1992.
19. Kovacs A and Kovacs G: Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosome Cancer 4: 267-268, 1992.
20. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Brechlin RM, Klein G and Sümegi J: Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 85: 1571-1575, 1988.
21. Holzmann K, Blin N, Welter C, Zang KD, Seitz G and Henn W: Telomeric association and loss of telomeric DNA repeats in renal tumors. Genes Chromosome Cancer 6: 178-181, 1993.
22. Mehle C, Ljungberg B and Roos G: Telomere shortening in renal cell carcinoma. Cancer Res 54: 236-241, 1994.
23. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RD: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868, 1990.
24. Lange T de, Shiue L, Myers RD, Cox DR, Naylor SL, Killerey AM and Varmus HE: Structure and variability of human chromosome ends. Mol Cell Biol 10: 518-527, 1990.
25. Nuernberg P, Thiel G, Weber F and Epplen JT: Changes of telomere, lengths in human intracranial tumours. Hum Genet 91: 190-192, 1993.
26. Thoenes W, Störkel S and Rumpelt HJ: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181: 125-143, 1986.
27. Lagoda P, Seitz G, Epplen J and Issinger O: Increased detectability of somatic changes in the DNA from human tumors after probing with 'synthetic' and 'genome-derived' hypervariable multilocus probes. Hum Genet 84: 35-40, 1989.
28. Dahse R, Fiedler W, Ernst G, Kosmehl H, Schlichter A, Schubert J and Claussen U: Changes in telomere lengths in renal cell carcinomas. Cell Mol Biol 42: 477-485, 1996.
29. Shay JW and Woodring EW: The reactivation of telomerase activity in cancer progression. TIG 12: 129-131, 1996.
30. Wright WE and Shay JW: Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism? Trends Cell Biol 5: 293-297, 1995.
31. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256: 271-282, 1991.
32. Steel CM: Activation of telomerase in damaged liver cells: both how and how many? telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellula carcinomas - comment. Hum Exp Tox 15: 83-85, 1996.
33. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G and Ide T: Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55: 2734-2736, 1995.
34. Mehle C, Piatyszek MA, Ljungberg B, Shay JW and Roos G: Telomerase activity in human renal cell carcinoma. Oncogene 13: 161-166, 1996.
35. Mehle C, Ljungberg B, Stenling R and Roos G: DNA fingerprinting of renal cell carcinoma with special references to tumor heterogeneity. Genes Chromosome Cancer 6: 86-91, 1993.